Dr. Maly is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3991 Dutchmans Ln
Ste 405
Louisville, KY 40207Phone+1 502-899-3366Fax+1 502-629-2055
Education & Training
Ohio State University HospitalFellowship, Hematology and Medical Oncology, 2017- Ohio State University HospitalResidency, Internal Medicine, 2011 - 2014
Lewis Katz School of Medicine at Temple UniversityClass of 2011
Certifications & Licensure
IN State Medical License 2017 - 2025
KY State Medical License 2017 - 2025
OH State Medical License 2011 - 2018- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Convalescent Plasma in the Early Treatment of High-Risk Patients With SARS-CoV-2 (COVID-19) Infection Start of enrollment: 2020 Aug 14
- A Study of TAS1553 in Subjects With Relapsed or Refractory Acute Myeloid Leukemia (AML) and Other Myeloid Neoplasms Start of enrollment: 2020 Dec 21
Publications & Presentations
PubMed
- 107 citationsIncidence and risk of central nervous system metastases as site of first recurrence in patients with HER2-positive breast cancer treated with adjuvant trastuzumabErin M. Olson, Mahmoud Abdel-Rasoul, Joseph Maly, Christina Wu, Nan Lin
Annals of Oncology. 2013-06-01 - 13 citationsPertuzumab in Combination with Trastuzumab and Chemotherapy in the Treatment of HER2-Positive Metastatic Breast Cancer: Safety, Efficacy, and Progression Free SurvivalJoseph J. Maly, Erin Macrae
Breast Cancer. 2014-05-12 - 161 citationsContribution of male sex, age, and obesity to mechanical instability of the upper airway during sleepJason P. Kirkness, Alan R. Schwartz, Hartmut Schneider, Naresh M. Punjabi, Joseph J. Maly
Journal of Applied Physiology. 2008-06-01
Abstracts/Posters
- Venetoclax in Combination with Gilteritinib in Patients with Relapsed/Refractory Acute Myeloid Leukemia: A Phase 1b StudyClinically Relevant AbstractJoseph Maly, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Pharmacokinetic Exposure Equivalence and Preliminary Efficacy and Safety from a Randomized Cross over Phase 3 Study (ASCERTAIN study) of an Oral Hypomethylating Agent ...Joseph Maly, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
